Skip to content

The research of the clinical effect and mechanism of "Zhishen Tiaoxing" Tuina therapy on Chronic Fatigue Immune Dysfunction Syndrome

The research of the clinical effect and mechanism of "Zhishen Tiaoxing" Tuina therapy on Chronic Fatigue Syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000081
Enrollment
Unknown
Registered
2024-05-27
Start date
2024-06-01
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Fatigue Syndrome

Interventions

Tuina intervention group:"Zhishen Tiaoxing" Tuina Therapy
Control group:Cognitive behavior therapy

Sponsors

Affiliated Hospital of Changchun University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1) Meet the diagnostic criteria of disease; 2) Age between 18 and 60 years old, male and female; 3) The patient was in normal mind and could express his feelings to the doctor with fluent speech; 4) Patients have good compliance, can abide by the trial protocol and cooperate to complete the treatment project; 5)Patients agreed to receive the study regimen and signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1) Those who did not meet the study inclusion criteria; 2) any active disease that could explain chronic fatigue syndrome (definite diagnosis of gastrointestinal organic disease, hepatic and renal insufficiency, tumor or serious cardiovascular and cerebrovascular disease, endocrine system disease, motor system disease, autoimmune disease, infectious disease, diabetes mellitus, drug side effects or other mental disease); 3) pregnant or lactating women; 4) suffering from infectious diseases or skin infection damage, not suitable for Tuina treatment; 5) those who had significant changes in diet before the study; 6) patients who have received relevant treatment within 30 days or are participating in other clinical trials that may affect the evaluation of the results of this study.

Design outcomes

Primary

MeasureTime frame
Multidimensional Fatigue Inventory (MFI-20);

Secondary

MeasureTime frame
Musculoskeletal ultrasound examination;Plantar pressure;Infrared thermal imaging detection;Three-dimensional gait analysis;Visual analogue scale to evaluate fatigue severity (VAS-F);surface electromyography;Pittsburgh sleep quality index (PSQI);Subjective Cognitive Decline - 9 (SCD-9);the MOS item short from health survey (SF-36);

Countries

China

Contacts

Public ContactDeyu Cong

Department of Tuina, Affiliated Hospital of Changchun University of Traditional Chinese

congdeyu666@sina.com+86 15948000820

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026